Published on | 2 years ago
Programmes Horizon Europe Horizon 2020Yesterday the Commission launched the public consultation on the past, present and future of the EU’s Horizon research and innovation programmes 2014-2027. With this consultation, the Commission is collecting input which will be used for:
The public consultation allows participants to:
The consultation will be closed in February 2023.
More information can be found in the news article of the Directorate-General for Research and Innovation of the European Commission. The online consultation can be accessed via EU Survey.
For any question related to the consultation, please contact RTD-PUBLIC-CONSULTATION-HORIZON@ec.europa.eu.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Advanced Digital Skills Deployment: Best use of technologies European Digital Innovation Hubs
The next round of Digital Europe calls has been published on the Funding & Tenders Portal of the European Commission. This next round comprises 14 call topics in total, covering the subdomains AI, data & cloud (see call topics here and here) Advanced Digital Skills Deployment European Digital Innovation Hubs The calls will o... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.